Prognostic value of plasma EBV DNA for nasopharyngeal cancer patients during treatment with intensity-modulated radiation therapy and concurrent chemotherapy
, , , , e
28 apr 2018
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Research Article
Pubblicato online: 28 apr 2018
Pagine: 195 - 203
Ricevuto: 21 dic 2017
Accettato: 04 feb 2018
DOI: https://doi.org/10.2478/raon-2018-0016
Parole chiave
© 2018 Chawalit Lertbutsayanukul, Danita Kannarunimit, Anussara Prayongrat, Chakkapong Chakkabat, Sarin Kitpanit, Pokrath Hansasuta, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Lertbutsayanukul, Chawalit
Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial HospitalBangkok, Thailand
Kannarunimit, Danita
Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial HospitalBangkok, Thailand
Prayongrat, Anussara
Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial HospitalBangkok, Thailand
Chakkabat, Chakkapong
Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial HospitalBangkok, Thailand
Kitpanit, Sarin
Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial HospitalBangkok, Thailand
Hansasuta, Pokrath
Division of Virology, Department of Microbiology, Faculty of Medicine, Chulalongkorn UniversityBangkok, Thailand